Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

BackgroundPneumococcal conjugate vaccines (PCVs) have reduced pneumococcal diseases globally. Pneumococcal genomic surveys elucidate PCV effects on population structure but are rarely conducted in low-income settings despite the high disease burden.MethodsWe undertook whole-genome sequencing (WGS) of 660 pneumococcal isolates collected through surveys from healthy carriers 2 years from 13-valent PCV (PCV13) introduction and 1 year after rollout in northern Malawi. We investigated changes in population structure, within-lineage serotype dynamics, serotype diversity, and frequency of antibiotic resistance (ABR) and accessory genes.ResultsIn children <5 years of age, frequency and diversity of vaccine serotypes (VTs) decreased significantly post-PCV, but no significant changes occurred in persons ≥5 years of age. Clearance of VT serotypes was consistent across different genetic backgrounds (lineages). There was an increase of nonvaccine serotypes (NVTs)-namely 7C, 15B/C, and 23A-in children <5 years of age, but 28F increased in both age groups. While carriage rates have been recently shown to remain stable post-PCV due to replacement serotypes, there was no change in diversity of NVTs. Additionally, frequency of intermediate-penicillin-resistant lineages decreased post-PCV. Although frequency of ABR genes remained stable, other accessory genes, especially those associated with mobile genetic element and bacteriocins, showed changes in frequency post-PCV.ConclusionsWe demonstrate evidence of significant population restructuring post-PCV driven by decreasing frequency of vaccine serotypes and increasing frequency of few NVTs mainly in children under 5. Continued surveillance with WGS remains crucial to fully understand dynamics of the residual VTs and replacement NVT serotypes post-PCV.

More information Original publication

DOI

10.1093/cid/ciz404

Type

Journal article

Publication Date

2020-03-01T00:00:00+00:00

Volume

70

Pages

1294 - 1303

Total pages

9

Addresses

P, a, r, a, s, i, t, e, s, , a, n, d, , M, i, c, r, o, b, e, s, , P, r, o, g, r, a, m, m, e, ,, , W, e, l, l, c, o, m, e, , S, a, n, g, e, r, , I, n, s, t, i, t, u, t, e, ,, , W, e, l, l, c, o, m, e, , G, e, n, o, m, e, , C, a, m, p, u, s, ,, , C, a, m, b, r, i, d, g, e, .

Keywords

Nasopharynx, Humans, Streptococcus pneumoniae, Pneumococcal Infections, Pneumococcal Vaccines, Vaccines, Conjugate, Carrier State, Child, Infant, Malawi, Metagenomics, Serogroup